腮腺恶性肿瘤切除后面神经重建:显微技术与功能结局的系统综述
总体44%患者达House-Brackmann I-III级,术后放疗未损害移植神经功能,咬肌神经转位再支配早于电缆移植;证据确定性为极低。
要点
- 即刻面神经重建无论采用何种技术均可获得有意义的功能恢复。
- 咬肌神经转位再支配约4-6个月,早于电缆移植的6-13个月。
- 大范围缺损或长神经缺损可优先考虑血管化神经游离瓣。
核心结论
- 即刻面神经重建可提供有意义的功能恢复,且与所采用技术无关。
- 术后放疗不损害移植神经功能。
- 咬肌神经转位再支配更早,血管化神经游离瓣可能更适合大范围缺损或长神经缺损。
研究设计与样本
- 遵循PRISMA 2020的系统综述,注册号PROSPERO CRD42025643307。
- 检索Scopus、Web of Science和PubMed/MEDLINE,自建库至2025年6月。
- 由两名评价者独立筛选文献并提取数据,采用Newcastle-Ottawa量表和MINORS评估偏倚风险,GRADE评估证据确定性。
主要发现
- 识别出6个技术亚组:非血管化电缆移植(n=155)、混合供体移植(n=38)、血管化胸背神经游离瓣(n=46)、咬肌神经转位(n=27)、静脉导管(n=3)和联合方式(n=43)。
- 在10项采用标准分级的研究中,44%患者达House-Brackmann I-III级(范围24-100%)。
- 四项比较性研究中,术后放疗未损害移植神经功能。
- 咬肌神经转位再支配时间为4-6个月,电缆移植为6-13个月。
- 偏倚风险为中等(NOS 6-9/9;MINORS 8-11/16);总体证据确定性为极低(GRADE)。
关键数值与推荐
- House-Brackmann I-III级在10项标准分级研究中占44%(范围24-100%)。
- 咬肌神经转位再支配时间4-6个月,电缆移植6-13个月。
- 偏倚风险评估:NOS 6-9/9,MINORS 8-11/16;GRADE证据确定性为极低。
临床怎么用
- 面神经牺牲后应行即刻显微重建,术式选择可依据缺损大小与神经缺损长度个体化。
- 大范围缺损或长神经缺损可优先考虑血管化神经游离瓣。
- 需更早恢复者可考虑咬肌神经转位。
- 术后放疗不应成为推迟或放弃移植神经重建的理由。
局限性
- 无对照试验,技术选择仍属经验性。
- 总体证据确定性为极低(GRADE)。
- 纳入研究偏倚风险为中等(NOS 6-9/9;MINORS 8-11/16)。
- 缺乏标准化的结局报告,需前瞻性比较试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radical parotidectomy with facial nerve sacrifice results in complete ipsilateral facial paralysis. Although immediate microsurgical reconstruction is the standard of care, no comparative trials have been conducted, and technique selection remains empirical. METHODS: A PRISMA 2020-compliant systematic review (PROSPERO: CRD42025643307) was conducted. Scopus, Web of Science, and PubMed/MEDLINE were searched from inception to June 2025. Two reviewers independently screened studies and extracted data. Risk of bias was assessed using the Newcastle-Ottawa Scale and MINORS. Certainty of evidence was evaluated using GRADE. RESULTS: Eighteen studies enroling 312 patients across ten countries (2000-2021) were included. Six technique subgroups were identified: non-vascularised cable graft (n=155), mixed-donor graft (n=38), vascularised thoracodorsal nerve free flap (n=46), masseteric nerve transfer (n=27), venous conduit (n=3) and combination approaches (n=43). House-Brackmann Grade I-III was achieved in 44% of patients across ten standard-grading studies (range, 24-100%). Postoperative radiotherapy did not impair graft function in four comparative studies. Masseteric nerve transfer yielded earlier reinnervation (4-6 months) than cable grafting (6-13 months). Risk of bias was moderate (NOS 6-9/9; MINORS 8-11/16). Overall certainty of evidence was Very Low (GRADE). CONCLUSIONS: Immediate facial nerve reconstruction provides meaningful functional recovery regardless of technique, and postoperative radiotherapy does not impair graft function. Masseteric nerve transfer offers earlier reinnervation; vascularised nerve-free flaps may be preferred for large defects or long neural gaps. A decision-making framework is proposed; prospective comparative trials with standardised outcome reporting are required.
引用
- Fernandez-Diaz OF, Retchkiman M, Garcia-Romero JM, et al. Facial nerve reconstruction following parotidectomy for malignancy: A systematic review of microsurgical techniques and functional outcomes. J Plast Reconstr Aesthet Surg. 2026. PMID: 42497567. doi:10.1016/j.bjps.2026.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。